ConductScience.org, home

Trial · NCT07625371

Registered outcomes22

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber and Percentage of Participants Reaching Each Recruitment and Participation MilestoneFrom screening through the fifth laboratory visit, up to 6 weeks per participant
Recruitment and participant flow were summarized as the number and percentage of individuals who were screened, preliminarily eligible, ineligible, individually contacted or offered participation, not contacted because recruitment ended, nonresponsive, declined, consented and completed the baseline/familiarization visit, withdrew before randomization, randomized, and completed all experimental visits.
PrimaryNumber and Percentage of Randomized Participants Who Completed All Experimental VisitsFrom randomization after the baseline/familiarization visit through the fifth laboratory visit, an average of 32 days
Post-randomization retention was summarized as the number and percentage of randomized participants who completed all four experimental visits. Reasons for post-randomization withdrawal or noncompletion were documented when available.
PrimaryNumber and Percentage of Planned Experimental Sessions CompletedFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Experimental session completion was summarized as the number and percentage of planned experimental sessions that were started and the number and percentage of started sessions in which participants completed the full 25-minute treadmill bout. Session completion was summarized overall and by condition.
PrimaryNumber of Participants With Safety Events During Experimental Treadmill SessionsFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Safety was summarized as the number of participants with documented adverse events, near-falls, safety-harness events, participant requests to stop, early stops due to dizziness, pain, unusual shortness of breath, discomfort, loss of balance, unsafe positioning, equipment malfunction, or staff judgment that continuing would be unsafe.
PrimaryMean Feeling Scale Score During Each Treadmill Exercise PhaseFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Emotional feeling was measured using the Feeling Scale, an 11-point single-item measure ranging from -5 to +5, with higher scores indicating more positive affective valence. Mean or model-estimated mean scores were summarized by condition and treadmill phase.
PrimaryMean Physical Comfort/Tiredness Rating During Each Treadmill Exercise PhaseFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Physical comfort/tiredness was measured using an 11-point single-item rating ranging from -5 to +5, with higher scores indicating greater physical comfort or lower tiredness. Mean or model-estimated mean scores were summarized by condition and treadmill phase.
SecondaryNumber and Percentage of Experimental Sessions Delivered as PlannedFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Protocol fidelity was summarized as the number and percentage of started experimental sessions delivered using the participant-specific treadmill speed protocol, assigned audio condition, safety harness, front-handle contact procedure, and planned 25-minute treadmill duration, without documented protocol deviations.
SecondaryPercentage of Expected Affective-Experience and Acceptability Data ObtainedFrom the second laboratory visit through the final comparative interview at the fifth laboratory visit, an average of 24 days
Data completeness was summarized as the percentage of expected observations obtained for emotional feeling, physical comfort/tiredness, perceived attentional/interoceptive cue-following, and final comparative interview responses.
SecondaryMean Custom Perceived Attentional and Interoceptive Cue-Following Rating ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Perceived attentional and interoceptive cue-following was measured after each experimental treadmill session using a custom single-item scale titled the Perceived Attentional and Interoceptive Cue-Following Rating. Possible scores ranged from 1 to 10. Higher scores indicate greater perceived success clearing the mind and focusing on breathing during exercise, representing stronger engagement with the intended attentional and interoceptive exercise instructions. Mean scores were summarized by condition and exposure.
SecondaryNumber and Percentage of Participants Reporting Condition PreferenceFrom the baseline/familiarization visit through the final comparative interview at the fifth laboratory visit, an average of 32 days
Condition preference was summarized as the number and percentage of participants who preferred ECI-AE, preferred the matched eyes-open control condition, or reported no preference during the final comparative interview.
SecondaryNumber and Percentage of Participants Reporting Better, Worse, or Same Second ECI-AE ExposureFrom the baseline/familiarization visit through the final comparative interview at the fifth laboratory visit, an average of 32 days
Adaptation to ECI-AE was summarized as the number and percentage of participants who described the second ECI-AE exposure as better, worse, or the same compared with the first ECI-AE exposure. Open-ended explanations were used to characterize perceived familiarity, comfort, confidence, or remaining concerns.
SecondaryMean Postexercise Seated-Recovery Feeling Scale ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Postexercise seated-recovery emotional feeling was measured using the Feeling Scale, an 11-point single-item measure ranging from -5 to +5, with higher scores indicating more positive affective valence. Mean scores were summarized by condition and exposure.
SecondaryMean Postexercise Seated-Recovery Physical Comfort/Tiredness RatingFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Postexercise seated-recovery physical comfort/tiredness was measured using an 11-point single-item rating ranging from -5 to +5, with higher scores indicating greater physical comfort or lower tiredness. Mean scores were summarized by condition and exposure.
SecondaryChange From Pre-Session to Post-Session State Anxiety ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
State anxiety was measured before and after each experimental session using the State-Trait Anxiety Inventory-State Form. The scale includes 20 items rated from 1 to 4, producing a total score ranging from 20 to 80 after appropriate reverse scoring. Higher scores indicate greater state anxiety. Change scores were calculated as post-session score minus pre-session score and summarized by condition.
SecondaryChange From Pre-Session to Post-Session Affective State ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Exercise-induced affective state was measured before and after each experimental session using the Exercise-Induced Affect Scale questionnaire. Mean item scores ranged from 1 to 5, with higher scores indicating greater intensity of the specific affective state being rated. Change scores were calculated as post-session score minus pre-session score and summarized by condition.
SecondaryMean Post-Session Condition-Specific Exercise Attitude ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Exercise attitude was measured after each experimental session using custom bipolar adjective ratings of the completed exercise condition. Items were rated from 1 to 9. Higher scores indicate a more favorable attitude toward the completed exercise condition. Mean scores were summarized by condition.
SecondaryMean Post-Session Condition-Specific Exercise Intention ScoreFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Exercise intention was measured after each experimental session using custom condition-specific items rated from 1 to 5. Higher scores indicate stronger intention to perform the relevant exercise type in the future. After matched eyes-open control sessions, items assessed intention and motivation for treadmill exercise. After ECI-AE sessions, items assessed intention and motivation for meditation-infused or eyes-closed interoceptive aerobic exercise. Mean scores were summarized by condition.
OtherMean Heart Rate During Treadmill Exercise and RecoveryFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Heart rate was recorded in beats per minute using a heart-rate strap during experimental visits. Mean heart rate values were summarized during the 25-minute treadmill exercise bout and postexercise seated recovery period by condition, session, treadmill phase, or recovery period. Higher values indicate higher heart rate in beats per minute.
OtherMean Heart-Rate Variability During Seated Rest and RecoveryFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Heart-rate variability was derived from heart-rate recordings collected during seated rest and postexercise seated recovery periods. HRV indices, such as root mean square of successive differences or other protocol-specified HRV metrics, were summarized by condition and time period. Higher scores indicate greater heart-rate variability for the specific HRV metric reported.
OtherChange From Pre-Exercise to Postexercise Systolic and Diastolic Blood PressureFrom the second laboratory visit through the fifth laboratory visit, an average of 24 days
Systolic and diastolic blood pressure were measured in millimeters of mercury before treadmill exercise, immediately after treadmill exercise, and after postexercise seated recovery at each experimental visit. Change scores were summarized by condition. Higher values indicate higher blood pressure.

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07625371/registered